2022 American Society of Clinical Oncology (ASCO) Annual Meeting
June 03-07, 2022 | Chicago, IL, United States
American Association for Cancer Research (AACR) Annual Meeting 2022
April 08-13, 2022 | New Orleans, LA, United States
Tumor Metabolism
January 16-20, 2022 | Banff, AB, Canada
Immunometabolism at the Crossroads of Obesity and Cancer
January 16-20, 2022 | Banff, AB, Canada
Mayo Clinic Radiation Oncology: Current Practice and Future Direction
January 17-21, 2022 | Lahaina, HI, United States
Jefferson Winter CME 2021: What Every Doctor Should Know
January 18-21, 2022 | Snowmass Village, CO, United States
Mayo Clinic Pathology Update 2022
January 20-22, 2022 | Phoenix, AZ, United States
ASCO® 2022 Gastrointestinal Cancers Symposium
January 20-22, 2022 | San Francisco, CA, United States
Androgen deprivation therapy use and duration with definitive radiotherapy for localized prostate cancer: An individual patient data meta-analysis
The Lancet Oncology
Plasma IL-6 and TNF-α levels correlate significantly with grading changes in localized prostate cancer
The Prostate
Pre-existing castration-resistant prostate cancer–like cells in primary prostate cancer promote resistance to hormonal therapy
European Urology
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival
Clinical Colorectal Cancer
Skin cancer risk among testicular germ‐cell cancer survivors: A systematic review and meta‐analysis
Journal of the European Academy of Dermatology and Venereology